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A tightly regulated balance of proliferation and cell
death of intestinal epithelial cells (IECs) is essential
for maintenance of gut homeostasis. Survivin is
highly expressed during embryogenesis and in
several cancer types, but little is known about its
role in adult gut tissue. Here, we show that Survivin
is specifically expressed in transit-amplifying cells
and Lgr5+ stem cells. Genetic loss of Survivin in
IECs resulted in destruction of intestinal integrity,
mucosal inflammation, and death of the animals.
Survivin deletion was associated with decreased
epithelial proliferation due to defective chromosomal
segregation. Moreover, Survivin-deficient animals
showed induced phosphorylation of p53 and H2AX
and increased levels of cell-intrinsic apoptosis in
IECs. Consequently, induced deletion of Survivin in
Lgr5+ stem cells led to cell death. In summary,
Survivin is a key regulator of gut tissue integrity by
regulating epithelial homeostasis in the stem cell
niche.
INTRODUCTION
The intestinal epithelium is a vigorously self-renewing tissue
where stem cells and transit-amplifying (TA) cells at the base of
the crypts give rise to terminally differentiated cells. In the small
intestine, these cells migrate up toward the villous tip, from
where they are shed into the lumen to be replaced by neigh-
boring cells (Sancho et al., 2003). Since the epithelium acts as
a barrier against a plethora of antigens in the intestinal lumen,
the balance between proliferation and cell death must be tightly
regulated tomaintain homeostasis in the intestinal tract. Accord-
ingly, an overproduction of intestinal epithelial cells (IECs) can
lead to the development of tumors, whereas excessive death
of IECs can cause breakdown of the intestinal barrier and may
lead to invasion of bacteria. The intestinal stem cell niche is built1062 Cell Reports 14, 1062–1073, February 9, 2016 ª2016 The Authoof stem cells intermingled with Paneth cells located at the 0 to +4
position and TA cells, located above the +4 position (Barker
et al., 2012). Intestinal stem cells are characterized by the
expression of distinct genes, for instance the leucine-rich
repeat-containing G-protein-coupled receptor 5 (Lgr5), B lym-
phomaMo-MLV insertion region 1 homolog (Bmi1), and Olfacto-
medin 4 (Olfm4) (Barker et al., 2010). TA cells are fast-cycling
progeny of stem cells and important for replacement of shed
epithelial cells (Barker et al., 2012).
Survivin is amember of the inhibitors of apoptosis (IAP) protein
family and expressed during embryonic development. Embryos
with homozygous general deletion of Survivin failed to survive
beyond embryonic day 4.5 (E4.5) (Uren et al., 2000), whereas
heterozygous deletion of the Survivin gene allowed normal
development, although embryos were more sensitive to Fas-
mediated hepatic apoptosis (Conway et al., 2002). In contrast
to its well-described function in embryonic development, the
role of Survivin in adult tissue remains unclear, as differentiated
cells show almost no Survivin expression (Fukuda and Pelus,
2006). The role of Survivin seems to be highly tissue dependent,
as deficiency for Survivin in pancreas and liver showed no severe
effect on tissue homeostasis, while deficiency in the brain and
heart led to premature death of the animals (Jiang et al., 2005;
Levkau et al., 2008). On the molecular level, Survivin is linked
to several cellular circuitries including the inhibition of apoptosis,
stress responses, angiogenesis, and the p53 checkpoint, de-
pending on the cellular context and the tissue (Altieri, 2006).
Several of these functions are key regulators of cellular homeo-
stasis and involved in tumor development. Importantly, Survivin
is highly expressed in several cancer types, including colorectal
cancer (Fukuda and Pelus, 2006). As a consequence of this can-
cer-cell-specific overexpression of Survivin, considerable efforts
have been made to target Survivin for cancer therapy by the use
of antagonizing agents or immunotherapies (Mobahat et al.,
2014). Moreover, Survivin appears to be a reliable diagnostic
marker to predict colorectal cancers (Miura et al., 2011), and
high Survivin levels are associated with poor overall survival
(Huang et al., 2013). Despite the important role of Survivin in
several tissues, the function of Survivin in the gut is currently
unknown. Using conditional knockout mice allowing control ofrs
(legend on next page)
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Survivin expression in a temporal and tissue-specific manner,
we here demonstrate a crucial importance for Survivin expres-
sion in epithelial progenitor cells for gut development as well
as immune and tissue homeostasis.
RESULTS
Deletion of Survivin in the Intestinal Epithelium Leads to
Severe Destruction of Gut Morphology
Survivin is known to be highly expressed during embryonic
development. To investigate whether Survivin might also be ex-
pressed in the adult intestinal epithelium, we initially analyzed
Survivin in the gut of mice and humans under physiologic condi-
tions. In agreement with previously published data (Boman et al.,
2009; van de Wetering et al., 2002), we observed expression of
Survivin in healthy gut samples of adult mice and humans. Survi-
vin expression was restricted to the intestinal epithelium of the
crypt compartment of the small and large intestine of both
mice and humans (Figures 1A and S1A). Detailed analysis of Sur-
vivin expression within the crypts of the small intestine of mice
showed positivity of almost 50% of total cells in the stem cell
niche at the bottom of the crypt (0 to +4) and positivity of more
than 70% of total cells in the TA cell area (+5 to +15). No Survivin
expression was found outside of the crypts (>+15; Figure 1B). To
further narrow down which cell types in the crypt compartment
expressed Survivin, we simultaneously stained for Survivin and
specific cell markers. We observed expression of Survivin in
half of the Lgr5-positive cells and in two-thirds of Ki67 positive
cells (Figures 1C and S1B), suggesting that the protein is ex-
pressed in stem cells at the crypt base and in mitotic cells of
the TA cell area. In support of this conclusion, we could show
increased Survivin expression in the G2/M phase of cell-cycle-
sorted IECs (Figure S1C). To further investigate whether Survivin
in IECs is important for gut homeostasis in adult mice,
we crossbred Survivinfl/fl mice to mice carrying the inducible
CreERT2 recombinase under the control of the Villin promotor
(Villin-CreERT2). To induce the Survivin knockout in IECs in adult
mice (SurviviniDIEC) and investigate the role of Survivin in the
mouse intestine, we treated 6- to 12-week-old mice with a daily
injection of 1 mg tamoxifen (Figure 1D). Knockout of the Survivin
gene was confirmed by allele-specific PCR (Figure S1D) and the
loss of the protein by western blot analysis of isolated intestinalFigure 1. Survivin Is Exclusively Expressed in the Intestinal Crypt Com
(A) Expression of Survivin (red) in mouse and human terminal ileum as well as
E-cadherin (green). Scale bars, 25 mm. Nuclei were counterstained with Hoechst
(B) Left: representative staining for Survivin (red) and E-cadherin (green) of a small
the crypt were sectioned into the lower crypt zone (0 to +4), the upper crypt zone (+
Survivin-positive cells per crypt zone (nR 6 crypts per group). Data represent m
(C) Representative confocal microscopy pictures of small intestine of Survivinfl m
EGFP in Lgr5EGFP mice (green) (bottom). Nuclei were counterstained with Hoechs
single-positive cells (Survivin, Ki67, and Lgr5) as well as double-positive cells (Su
(D) Survivinfl/fl Villin-CreERT2mice and Survivinfl/fl Villin-CreERT2+ mice were used
(final concentration 1 mg) to induce Survivin deletion specifically in IECs (Survivi
(E) Western blot analysis shows reduced Survivin level in IECs of SurviviniDIEC m
(F) Relative weight of control and SurviviniDIEC mice during tamoxifen treatment wa
(n = 3 mice per group). Experiment was repeated three times with similar results
(G) Kaplan-Meier survival curve showing survival of control and SurviviniDIEC mic
See also Figure S1.
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started losing weight following Survivin deletion in adult mice
(Figure 1F), and all animals died within 6 to 10 days (Figure 1G).
Compared to control littermates, SurviviniDIEC mice showed
significantly reduced gut length (Figure 2A). Moreover, high-res-
olution video endoscopy indicated massive destruction of the
villous structure in the small intestine and colon of SurviviniDIEC
mice compared to control mice (Figure 2B). Additional micro-
scopic analysis (Figure 2C, left) and histological scoring (Fig-
ure 2C, right) revealed epithelial erosions, loss of the regular
crypt-villus architecture, and overall severe tissue destruction
of the small intestine and colon in SurviviniDIEC mice compared
to controls. Consequently, we found infiltration of neutrophils
after 96 hr following induction of Survivin deletion, shown by
the expression of myeloperoxidase (Figure S1E). Moreover
mRNA expression of tumor necrosis factor alpha (TNF-a) was
also highly upregulated in SurviviniDIEC mice 96 hr after Survivin
deletion correlatingwith an infiltration of neutrophils (Figure S1F).
In summary, our data demonstrate the essential function for
Survivin for embryonic development as well as for adult tissue
homeostasis in the gut. Loss of Survivin leads to irreparable tis-
sue damage followed by severe immune responses.
Survivin Is Essential for Maintenance of the
Transit-Amplifying and Stem Cell Niche
Loss of Survivin in IECs led to a dramatic phenotype that was
affected by destruction of complete gut architecture, indicating a
disturbance in epithelial cell homeostasis. As mentioned above,
Survivin expression is restricted to the crypt. In agreement with
the severe phenotype observed after tamoxifen injection, Survi-
vin expression in the lower crypt compartment of small intestine
and colon of SurviviniDIEC mice was almost completely dimin-
ished (Figures 3A and S1G). The reduction of Survivin had only
little influence on the expression of differentiated epithelial cell
types shown by the expression of specific genes (Figure S2A,
top). All differentiated epithelial cell types could be found in con-
trol and SurviviniDIEC mice, shown by staining of specific cell
types. Goblet cells and Paneth cells showing signs of degranula-
tion but are expressed in equal amounts (Figure S2A, bottom). In
sharp contrast, the expression of stem cell related genes like
Ofm4 and Lgr5 were significantly reduced after Survivin deletion
(Figure 3B). We further investigated if this reduction of stem cellpartment and Essential for Survival
colon tissue. High-power views show Survivin expression (red) together with
33342 (blue).
intestinal crypt. Nuclei were counterstained with Hoechst 33342 (blue). Cells of
5 to +15) and non-crypt zone (> +15). Right: graph represents the percentage of
ean values ± SD.
ice stained for Survivin (red) and Ki67 (green) (top) as well as Survivin (red) and
t 33342 (blue). Scale bars, 10 mm. Graphs represent the average appearance of
rvivin/Ki67 and Survivin/Lgr5) in the crypt. Data represent mean values ± SD.
to analyze Survivin deletion in the intestine. Mice were injected with tamoxifen
niDIEC).
ice after 4 days of tamoxifen treatment. Internal controls: Villin and GAPDH.
s monitored over time and is indicated as percent (%) of the initial weight ± SD
.
e after a daily injection of tamoxifen (n = 7 mice per group).
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Figure 2. Deletion of Survivin in the In-
testinal Epithelium Leads to Disruption of
Intestinal Tissue Homeostasis
(A) Representative pictures of the intestine of
control and SurviviniDIEC mice treated for 4 days
with tamoxifen and statistical analysis of the gut
length (n = 4mice per group). Data represent mean
values + SD.
(B) Representative endoscopic pictures of the
small intestine (SI) and the colon of control and
SurviviniDIEC mice 6 days after tamoxifen treat-
ment.
(C) Left: histological H&E stainings of small intes-
tine and colon of control and SurviviniDIEC mice.
Scale bars, 500 mm; inset, 100 mm. Right: histo-
logical scoring evaluating tissue destruction and
epithelial erosions of small intestine (SI) and colon
from SurviviniDIEC and control mice 5 days after
tamoxifen injection. Data represent mean values +
SD (nR 6 mice per group). Arrows indicate intes-
tinal epithelial erosions.
See also Figure S1.marker genes leads to a proliferation defect in IECs and pulse-
labeled IECs in vivo with bromodeoxyuridine (BrdU), which re-
vealed greatly reduced proliferation within 48 hr after tamoxifen
injection in SurviviniDIEC mice (Figure 3C). This was confirmed
by demonstrating reduced expression of Ki67 when Survivin
was deleted (Figure S2B). Therefore, our data indicate that Sur-
vivin depletion leads to dysregulations in the epithelial turnover.
We next investigated whether excessive cell death might be
the cause for rapid tissue destruction after deletion of Survivin.
Mice were treated with tamoxifen for the duration of 96 hr, and
tissue was analyzed every 24 hr. We detected significantly
increased apoptosis, marked by elevated numbers of TUNEL
and activated caspase-3-positive cells in SurviviniDIEC mice at
the crypt bottom already after 24 to 48 hr (Figure 4A). Interest-
ingly, double staining for Ki67 and TUNEL in SurviviniDIEC mice
showed pronounced cell death in proliferating cells within the
crypt in an area where TA cells and stem cells reside (Figure 4B).
This could be confirmed by western blot analysis showing
increased levels of activated caspase-3 and caspase-8 (Fig-
ure 4C). Cell death following Survivin deletion was further de-
tected in in vitro generated organoids of SurviviniDIEC mice after
stimulation with tamoxifen for 4 days (Figures 4D and S2C), sug-
gesting that cell deathwas induced by a cell-intrinsicmechanism
rather than death receptor signaling. This conclusion was further
supported by crossing inducible Survivin deficient mice on a
Caspase-8 deficient (Casp8/SurviviniDIEC) or a RIPK3 deficient
(RIPK3/SurviviniDIEC) background to evaluate whether either
excessive extrinsic apoptosis or necroptosis could explain
the severe phenotype of SurviviniDIEC mice. As indicated by his-
tochemical analysis, neither genotype could rescue the lethal
outcome of Survivin deletion (Figure S3A). Similarly, neitherCell Reports 14, 1062–1073,blocking of caspase-8, RIPK3, or a
combination of both, nor blocking of
TNF-a, prevented organoid death in vitro
following deletion of Survivin, as indicated
by propidium iodide (PI) staining andmorphological disintegration (Figures S3B and S3C). In sum-
mary, our data support the view that loss of Survivin specifically
induces cell death in cycling cells at the crypt bottom by a
primary cell-intrinsic mechanism that affects the regenerative
potential of the epithelium leading to severe gut pathology.
Since Lgr5-expressing stem cells at the crypt bottom are
considered an essential source for intestinal epithelial regenera-
tion, we crossed Lgr5-EGFP-IRES-CreERT2 mice to Survivinfl/fl
mice (Lgr5iDSurvivin) in order to directly analyze the effects of
loss of Survivin in the stem cell niche. We could confirm the
mosaic pattern of EGFP expression of the Lgr5-EGFP-IRES-
CreERT2 construct in this mouse model (Barker et al., 2010).
Importantly, Lgr5iDSurvivin mice showed a reduction of the EGFP
signal in the small intestine as well as the colon after 5 days of
tamoxifen treatment (Figure S4A). Furthermore, flow-cytome-
try-based analysis of isolated Lgr5-EGFP-expressing stem cells
from mice injected with tamoxifen for 3 days indicated a reduc-
tion of EGFP expression (Figure 5A). To provide additional evi-
dence for a role of Survivin in Lgr5 expressing stem cells, we
generated organoids from control and Lgr5iDSurvivin mice in the
presence of CHIR99021, an inhibitor of the glycogen synthase ki-
nase 3 (GSK-3), and valproic acid, a histone deacetylase (HDAC)
inhibitor, to expand the population of Lgr5-EGFP-expressing
stem cells (Figure S4B). Combined treatment with CHIR99021
and valproic acid has been demonstrated to maintain self-
renewal of mouse Lgr5+ intestinal stem cells (Yin et al., 2014).
Lgr5iDSurvivin organoids treated for 3 days with tamoxifen showed
increased levels of cell death as demonstrated by activated cas-
pase-3 staining and a reduced expression of EGFP (Figures 5B–
5D), indicating a loss of Lgr5 expressing cells. Activation of cell
death programs in Lgr5-expressing cells was further confirmedFebruary 9, 2016 ª2016 The Authors 1065
Figure 3. Loss of Survivin Leads to Cell Death in the Crypt Compartment
(A) Expression of Survivin (red) in small intestine and colon of SurviviniDIEC and control mice after 6 days of tamoxifen treatment. Scale bars, 100 mm; insets, 25 mm.
(B) mRNA expression of Survivin, Lgr5, Olfm4, and Ki67 in small intestinal tissue relative to HPRT from SurviviniDIEC and control mice after 4 days of tamoxifen
injection. Data represent mean values + SD (nR 6 mice per group).
(C) BrdU staining (brown) in the small intestine of SurviviniDIEC and control mice after 24 and 48 hr (h) tamoxifen (+T) treatment and pulse injection of BrdU. Nuclei
were counterstainedwith hematoxylin (blue). BrdU positive (+) intestinal epithelial cells (IECs) per high-power view (HPV) were counted for statistical analysis. Data
represent mean values + SD (n = 3 mice per group). Scale bar, 100 mm; high-power view scale bar, 50 mm.
See also Figure S2.by western blot analysis of isolated IECs indicating increased
levels of activated caspase-3 and activated caspase-8 in
Lgr5iDSurvivin mice 1 day after tamoxifen treatment (Figure 5E).
Furthermore, we could detect significantly more activated cas-
pase-3-positive cells in the crypt compartment of Lgr5iDSurvivin
mice after treatment with tamoxifen for 1 day (Figure S4C). Taken
together, our data demonstrated that Survivin is absolutely
essential for maintaining stem and progenitor cell homeostasis
and regeneration of the epithelium.1066 Cell Reports 14, 1062–1073, February 9, 2016 ª2016 The AuthoLoss of Survivin Leads to Abnormal Cell Division and
Signs of Mitotic Catastrophe in the Intestinal Crypt
Compartment
To gain further insight into triggering factors of progenitor cell
death in the absence of Survivin, we further analyzed crypt cells
using electron microscopy. Electron microscopy pictures
showed loss of the crypt architecture in SurviviniDIEC mice
when compare to control mice. Specifically, we observed a
loss of crypt base columnar cells, stem cells defined by theirrs
Figure 4. Survivin Deletion Leads to Intestinal Epithelial Cell Death
(A) Left: representative activated caspase-3 (red) and TUNEL (red) stainings of small intestine of SurviviniDIEC and control mice analyzed at indicated time points
after starting tamoxifen treatment. Nuclei were stained with Hoechst 33342 (blue). Scale bars, 50 mm. Right: statistics show quantification of activated caspase-3
and TUNEL positive (+) intestinal epithelial cells (IECs) per high-power view (HPV) of SurviviniDIEC and control mice during tamoxifen treatment. Data represent
mean values + SD (n = 4 mice per group).
(legend continued on next page)
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typical longitudinal nuclei (SCn). In contrast, the appearance of
Paneth cells (PCn) was unchanged (Figure 6A). Analysis of sub-
cellular structures within the crypt compartment revealed asym-
metric and giant nuclei (Figure 6A, bottom). In fact, the average
diameter of these nuclei was almost 3-fold larger after 4 days
of tamoxifen treatment in SurviviniDIEC mice than in control
mice (Figure 6B). Our findings are in agreement with previous re-
ports on Survivin in other tissues and indicate impaired cell divi-
sion in epithelial progenitor cells. To get detailed information as
to when these nuclear aberrations develop, we analyzed tissue
sections via confocal microscopy over time and counted cell
divisions in the crypt compartment. We could detect signs of
asymmetric cell divisions starting at 24–48 hr after tamoxifen
treatment in SurviviniDIEC mice, but not in control mice (Fig-
ure 6C). This time point overlapped with the burst of cell death
in the crypt compartment which peaked at 48 hr after tamoxifen
treatment in SurviviniDIEC mice, supporting the hypothesis that
some cells are able to survive but unable to maintain symmetric
cell division. Aberrant mitosis as shown by asymmetric and giant
nuclei indicates mitotic catastrophe. Survivin is a member of the
chromosomal passenger complex and was previously demon-
strated to play an important role during cytokinesis in other
tissues (Okada et al., 2004; Wu et al., 2009; Hagemann et al.,
2013). In fact, we detected a high upregulation of the DNA dam-
age marker g-H2AX, a hallmark of mitotic catastrophe, in IECs of
SurviviniDIEC mice, treated for 72 to 96 hr with tamoxifen (Fig-
ure 6D). Furthermore, we found an increased phosphorylation
of p53 in SurviviniDIEC mice, which was not detectable in control
mice (Figures 6D and S5A). This was supported by western blot
analysis, where we show elevated levels of activated caspase-2
in insolated crypt cells of SurviviniDIEC mice (Figure 6E). As a
response to DNA damage and the upregulation of phospho-
p53, we consequently found upregulated gene expression of
p21 and ddit3 after Survivin loss (Figure 6F). Collectively, our
data indicate that Survivin is essential for the homeostatic func-
tions of the stem cell compartment. Loss of Survivin expression
in epithelial progenitor cells causes mitotic catastrophe and le-
thal gut tissue degeneration.
DISCUSSION
The importance of Survivin for embryonic development has long
been known. However, the role of Survivin in adult tissues ap-
pears to be complex and is far less understood (Li and Brattain,
2006). In the present study, we investigated the functional role
of Survivin for gut homeostasis using a mouse model of condi-
tional Survivin deletion in the intestinal epithelium. The intestinal
epithelium is a strong self-regenerating tissue and harbors stem(B) Confocal microscopy pictures of stainings for TUNEL (red) together with Ki67
treatment. Nuclei were counterstained with Hoechst 33342 (blue). Scale bars, 20
(C) Detection of Survivin and activated caspase-3 and caspase-8 using western
SurviviniDIEC mice after 4 days of tamoxifen treatment. Villin and GAPDH were us
(D) Left: light microscopy and fluorescence microscopy pictures of small intestina
and without tamoxifen (T) treatment. Blue, Hoechst 33342 (cell nuclei); red, prop
Right: western blot of protein lysates of organoids from control and SurviviniDIEC
internal standard.
See also Figures S2 and S3.
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differentiated cells of the intestinal epithelium. During the last
decade, linage tracing identifiedmarkers for cells in the intestinal
crypt that showed stem cell potential. Among others, Lgr5
showed a robust stem cell pattern (Barker et al., 2007), and
isolated Lgr5+ cells were able to build crypt-villus structures
in vitro (Sato et al., 2009). Disturbances in the intestinal epithelial
homeostasis promote the development of gut-associated dis-
eases such as colorectal cancer and inflammatory bowel dis-
ease. Survivin is highly expressed in many tumors, and patients
with Survivin overexpressing tumors have a significant lower
survival rate (Huang et al., 2013; Zwerts et al., 2007) and a higher
risk for metastases (Chu et al., 2012). Our data confirm that Sur-
vivin is highly expressed in human as wells as mouse colorectal
cancer tissue. However, we also detected Survivin as a constitu-
tively expressed molecule in a subpopulation of epithelial cells
residing in the crypt compartment of the intestine.
The crypt compartment is a highly specialized niche where
stem cells and TA cells reside and warrant the renewal of the in-
testinal epithelium. Indeed, we could confirm the expression of
Survivin in Lgr5+ stem and precursor cells.
Survivin expression in TA cells as well as Lgr5+ stem cells is
essential as tamoxifen-induced deletion of Survivin in intestinal
epithelial cells resulted in significant weight loss of mice within
few days and abundant inflammation. Disruption of the intestinal
tissue architecture could be seen by loss of the villus-crypt struc-
ture, finally leading to death of the mice. A functional role of Sur-
vivin in Lgr5+ cells was directly confirmed by deletion of Survivin
specifically in these cells. Excessive caspase activation and cell
death could be detected in Lgr5iDSurvivin mice as early as 24 hr
after tamoxifen application. Of note, Survivin deletion only in
Lgr5-expressing stem cells did not lead to changes in gut tissue
morphology. This finding is consistent with previous reports
depleting Lgr5+ cells and has been explained by a functional
replacement of Lgr5+ stem cells with reserve stem cells, such
as Bmi1+ stem cells (Tian et al., 2011). Survivin has often been
described as a bi-functional protein involved in cell death regula-
tion on the one hand and cell division mechanisms on the other
hand. Tissue-specific knockouts of Survivin showed different
impacts on cellular homeostasis: mice with deletion of Survivin
in the liver showed no severe phenotype under non-stressed
conditions but an increased cell volume and nuclear-DNA con-
tent with a reduction of total hepatocyte numbers was observed
when compared to controls (Hagemann et al., 2013). In contrast,
heart-specific deletion of Survivin led to a premature cardiac
death, whichwas reported to result from a lowmitotic rate of car-
diomyocytes, but no increase in apoptosis could be detected
(Levkau et al., 2008). Similar observations were published for(green) in SurviviniDIEC and control mice after 24 and 48 hr (h) of tamoxifen (+T)
mm.
blot analysis of isolated intestinal epithelial cell protein lysates of control and
ed as internal standard.
l organoids from control and SurviviniDIEC mice after 4 days with tamoxifen (+T)
idium iodide (dead cells); green, calcein-AM (viable cells). Scale bars, 200 mm.
mice treated with (+T) or without (T) tamoxifen for 6 days. Actin was used as
rs
Figure 5. Survivin Is Important for Intestinal Regeneration and LGR5+ Stem Cell Survival
(A) Flow cytometry analysis of expression of Lgr5-EGFP in isolated crypt cells from Lgr5wt, Lgr5EGFP, and Lgr5iDSurvivin mice after 3 days of tamoxifen treatment.
Gating was performed on EpCam+ (epithelial cells), Survivin+, Zombie-Aqua (viable cells) population. Histogram shows EGFP-negative cell population (left peak)
and positive cell population (right peak).
(B) Small intestinal organoids from Lgr5wt, Lgr5EGFP, and Lgr5iDSurvivin mice grown and additionally treated for 3 days with CHIR99021 and valproic acid, in the
steady state (0 hr) and with (+T) or without (T) tamoxifen treatment for 72 hr (h). Scale bars, 250 mm; blue, Hoechst 33342 (cell nuclei); red, activated caspase-3
(dead cells); green, Lgr5-EGFP. Lgr5wt organoids show autofluorescence (green) of the lumen. Arrows indicate Lgr5-EGFP expressing organoids.
(C) Left: representative fluorescence microscopy pictures of small intestinal organoids derived from Lgr5wt, Lgr5EGFP and Lgr5iDSurvivin mice and treated with
tamoxifen (+T) for 3 days. Right: corrected mean total cell fluorescence +SD of organoids (n = 9 per group) from Lgr5wt, Lgr5EGFP, and Lgr5iDSurvivin mice. Values
were calculated using the integrated density, area, and mean fluorescence of the background readings.
(D) Confocal microscopy pictures of organoids from Lgr5wt, Lgr5EGFP, and Lgr5iDSurvivin mice grown and additionally treated for 3 days with CHIR99021 and
valproic acid, with (+T) and without (T) tamoxifen treatment for 72 hr (h). Scale bars, 50 mm; blue, Hoechst 33342 (cell nuclei); red, activated caspase-3 (dead
cells); green, Lgr5-EGFP. Lgr5wt organoids show autofluorescence (green) of the lumen.
(E) Western blot of protein lysates isolated from intestinal epithelial cells of Lgr5wt, Lgr5EGFP, and Lgr5iDSurvivin mice 1 day after tamoxifen injection. Actin and Villin
were used as internal controls.
See also Figure S4.
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Figure 6. Loss of Survivin Causes Aberrant
Mitosis in IECs
(A) Representative electron microscopy pictures of
the small intestinal crypt compartment showing
Paneth cells with Paneth cell nuclei (PCn) and stem
cells with stem cell nuclei (SCn) (top: 2,0003
magnification; bottom: 3,1503 magnification of
IEC cell nuclei) of control and SurviviniDIEC mice
after 7 days of tamoxifen treatment.
(B) Representative confocal pictures of IEC nuclei
stained with Hoechst 33342 (blue) of the small in-
testine of control and SurviviniDIECmice after 4 days
of tamoxifen treatment. Statistical analysis showed
nuclei almost thrice the size after 4 days of tamox-
ifen treatment in SurviviniDIEC mice compared to
controls. Data represent mean values + SD (nR 4
mice per group). Scale bars, 5 mm.
(C) Left: representative confocal pictures of
dividing cells in the crypt compartment of control
and SurviviniDIEC mice treated with tamoxifen for
indicated time points showing aberrant mitosis.
Nuclei were stained with Hoechst 33342 (blue).
Scale bars, 5 mm. Boxes show dividing cells within
the lower crypt area. Right: time-course analysis of
number (n) of IECs during the transition from
normal to aberrant mitosis in the crypt compart-
ment of SurviviniDIEC mice compared to controls
after starting tamoxifen treatment. Data represent
mean values + SD (n = 3 mice per group).
(D) Left: representative fluorescent microscopy
pictures showing g-H2AX (red) and phospho-p53
(red) positive IECs from control and SurviviniDIEC
mice together with E-cadherin (green) 4 days after
tamoxifen treatment in small intestinal sections.
Nuclei were counterstained with Hoechst 33342
(blue). Scale bars, 50 mm; high-power view scale
bars, 25 mm. Right: statistical analysis represent-
ing g-H2AX and phospho-p53 positive (+) IECs per
high-power view (HPV). Data represent mean
values + SD (n R 5 mice per group). Arrows indi-
cate g-H2AX- and phospho-p53-positive IECs.
(E) Western blot of protein lysates isolated from
crypt cells of control and SurviviniDIEC mice after
1 day of tamoxifen treatment detecting Survivin
and activated caspase-2. Villin was used as in-
ternal standard.
(F) mRNA expression of p21 and DNA-damage-
inducible transcript 3 (Ddit3) of small intestinal IECs
of SurviviniDIEC mice and control mice relative to
Villin after 4 days of tamoxifen treatment. Data
representmeanvalues+SD (nR6miceper group).
See also Figure S5.the deletion of Survivin in the pancreas. Reduction of the
pancreatic beta cell mass was due to a proliferation defect, but
increased apoptosis was not involved (Wu et al., 2009). In
contrast to the above findings, Survivin expression in the adult
intestinal epithelium was found crucial for gut homeostasis and
survival. One may speculate that the high need for continuously
replenishment in the gut determines the severe phenotype
observed in our study.
Moreover, Survivin deletion in IECs was associated with a sig-
nificant increase in apoptosis. To date, it is not clear if Survivin is
able to bind directly to caspases and repress their function (Ver-1070 Cell Reports 14, 1062–1073, February 9, 2016 ª2016 The Authodecia et al., 2000; Shin et al., 2001). In our studies, neither
Caspase-8 or RIPK3 inhibition nor combined inhibition of both
pathways could rescue the severe phenotype of Survivin defi-
ciency. Although we cannot fully exclude an indirect involvement
of these pathways at later stages, for example by inflammatory
mediators released during tissue damage, our data indicate
that neither extrinsic apoptosis nor necroptosis is functionally
essential for IEC death following depletion of Survivin. In
contrast, our study indicates that mitotic catastrophe is involved
in cell death induction upon Survivin deletion, as we observed
increased phosphorylation of p53 and H2AX and occurrence ofrs
aberrant cell division. Mitotic catastrophe is debated as a spe-
cific form of cell death defined by abnormal mitosis, a physiolog-
ical mechanism that seems to be important to remove cells with
genomic instability and therefore protects from cancer develop-
ment (Vitale et al., 2011).
The fact that Survivin is mainly expressed during embryo-
genesis and downregulated in adult tissue has been the
rational of using Survivin as a tumor-specific target molecule
for anti-cancer therapy. Accordingly, a number of drug
candidates aiming at interfering with Survivin expression and
function have been developed, such as the transcriptional
repressor YM155 (Kelly et al., 2013; Satoh et al., 2009; Tolcher
et al., 2008, 2012), antisense oligonucleotides (Talbot et al.,
2010), or even vaccines (Tanaka et al., 2013). YM155 is
currently investigated in phase 2 trials. Results of this investi-
gation are still pending.
In summary, our findings indicate that Survivin is constitutively
expressed in intestinal epithelial progenitor cells in the crypts of
Lieberk€uhn of adult mice and that deletion of Survivin from these
cells leads to defects in epithelial homeostasis, destruction of
tissue architecture, inflammation, and rapid death. Given our
studies, cancer therapies with drugs targeting Survivin in the
gut on the one hand could be efficient in eliminating cancer
stem cells. However, since our data show that Survivin is essen-
tial to preserve gut tissue homeostasis, targeting of Survivin with
high efficiency might be associated with a considerable risk for
patients treated systemically.EXPERIMENTAL PROCEDURES
Mice
Mice carrying loxP-flanked Survivin alleles (Survivinfl/fl) were kindly provided by
Hitoshi Okada (Okada et al., 2004). Villin-CreERT2 mice were described earlier
(el Marjou et al., 2004). Male and female mice were used at an age of 6 to
12 weeks for experiments. Conditional intestinal-epithelium-specific Survivin
knockout mice (SurviviniDIEC) were generated by breeding Survivinfl/fl mice to
Villin-CreERT2-expressing mice. Mice negative for the expression of Villin-
CreERT2 (Villin-CreERT2) served as controls in all experiments and are desig-
nated Survivinfl. Mice carrying loxP-flanked caspase-8 (Beisner et al., 2005) or
RIPK3 (Newton et al., 2004) alleles were crossed to inducible Survivinfl/fl/Villin-
CreERT2 mice to generate double-knockout mice (Casp8/SurviviniDIEC; RIPK3/
SurviviniDIEC). The Lgr5-EGFP-IRES-CreERT2mice have been described previ-
ously (Barker et al., 2007) and were crossbred to Survivinfl/fl mice to create
Lgr5iDSurvivin mice. Mice that did not express the transgene (Lgr5wt) and mice
that expressed the transgene but did not contain floxed Survivin alleles
(Lgr5EGFP) were used as controls for Lgr5iDSurvivin mice. To induce CreERT2 ac-
tivity, we used tamoxifen (100 mg/ml dissolved in ethanol; Sigma Aldrich)
further diluted in sunflower oil to a concentration of 10 mg/ml. Mice (including
controls) were intraperitoneally injected with 100 ml tamoxifen (10 mg/ml) to
receive a final tamoxifen dosage of 1 mg each day. For pulse BrdU labeling
of cells, mice were intraperitoneally injected with BrdU solution (1 mg; BD
Pharmingen) and sacrificed after 4 hr to analyze small intestinal tissue. Mice
were examined by measuring weight loss and monitoring of the intestine by
high-resolution mouse video endoscopy as previously described (G€unther
et al., 2011). For endoscopic analysis, mice were anaesthetized by gassing
with 2% isoflurane (Abbott) mixed with air.
Animal protocols were approved by the Institutional Animal Care and Use
Committee of the University of Erlangen. All mice were kept in individually
ventilated cages in compliance with the AnimalWelfare Act. Mice were housed
at a 12-hr day/night cycle with free access to tap water and food pellets. All
mice were kept in mixed cages to avoid cage effects during tamoxifen
treatment.Cell RHistology, Immunohistochemistry, and Electron Microscopy
Histological H&E stainings were performed by using formalin-fixed, dehy-
drated, and paraffin-embedded tissue. Diaminobenzidine staining for Survivin
and BrdU was performed by using the ABC staining kit (Santa Cruz) according
to the manufacturer’s protocol using the following primary antibodies: Survi-
vin (2808, Cell Signaling Technology) and BrdU (ab6326-250 Abcam).
Immunofluorescence stainings of cryo- or formalin-fixed, dehydrated, and
paraffin-embedded tissue sections were performed using the following pri-
mary antibodies: Survivin (2808, Cell Signaling Technology), E-cadherin
(MAB7481, R&D Systems), Ki67 (16667, Abcam), activated caspase-3 (9661,
Cell Signaling Technology), activated caspase-8 (8592, Cell Signaling Tech-
nology), phospho-p53 (9284, Cell Signaling Technology), and g-H2AX (5438,
Cell Signaling Technology). Slides were then incubated with biotinylated sec-
ondary antibodies (eBioscience), and signal amplifying was performed using
the TSA Cy3 or TSA fluorescein system as recommended by the manufacturer
(PerkinElmer) or were incubated by using streptavidin conjugated with Dylight
549 (Jackson ImmunoResearch). Gut tissue from Lgr5-EGFP-IRES-CreERT2
mice was fixed in 2% and 4% paraformaldehyde and subsequent incubation
in 30% sucrose solution overnight. Double staining for GFP and Survivin
was performed by using the anti-GFP antibody conjugated with Alexa 488
(Invitrogen, A21311). Apoptosis was detected by TUNEL staining using an
in situ cell death detection kit (Roche). Cell-cycle-sorted intestinal epithelial
cells were resuspended in 2%BSA/PBS and centrifuged on BSA-coated glass
slides using cytospin (Shandon). Cells were permeabilized by using 0.1%
Triton X-100 in PBS for 5 min prior to Survivin staining. Nuclei were counter-
stained with Hoechst 3342 (Invitrogen). Bright-field microscopy (Leica DMI
4000B), fluorescence microscopy (Leica DMI 4000B), and confocal micro-
scopy (Leica TCS SP5) were used for subsequent analyses. For electron mi-
croscopy, glutaraldehyde-fixed tissue was used. After embedding in Epon
Araldite, ultrathin sections were cut and analyzed using a Zeiss EM 906.
Intestinal Epithelial Cell Isolation and Western Blotting
IECs were isolated in EDTA/EGTA (Roth) separation buffer as previously
described (Nenci et al., 2007). Extraction of proteins was performed on ice by
using the mammalian protein extraction buffer (Thermo Scientific) supple-
mented with protease (EDTA-free) and phosphatase inhibitor tablets (Roche)
as well as PMSF (Roche). Proteins were separated by SDS-PAGE using aMini-
Protean-TGX gel (4%–15% polyacrylamide; Bio-Rad) and blotted to a nitro-
cellulose transfer membrane (Whatman). Membraneswere subsequently incu-
batedwith the following antibodies: Survivin (2808, Cell Signaling Technology),
b-Actin (ab49900, Abcam), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH; ab9482, Abcam), activated caspase-2 (ab2251, Abcam), caspase-3
(Cell Signaling Technologies), activated caspase-8 (8592, Cell Signaling Tech-
nology), phospho-p53 (Abcam), and Villin (sc-28283, Santa Cruz). As second-
ary antibody the horseradish peroxidase-linked anti-rabbit antibody (Cell
Signaling Technology) was used. Chemiluminescent detection was performed
by using an enhanced chemiluminescence substrate (Bio-Rad).
Gene Expression Analysis and Genotyping
Total RNA from IECs and tissue pieces was extracted using the RNA isolation
kit (Nucleo Spin RNAII; Macherey Nagel), and cDNA was synthesized by
reverse transcription (Script cDNA Synthesis Kit; Jena Bioscience). Real-
time PCR was performed with SYBR Green I Master (Roche) and QuantiTect
Primer assays (QIAGEN) or gene-specific unmodified DNA oligonucleotides
(EurofinsMWGOperon) using the Light Cycler 480 (Roche). Expression signals
were normalized to the level of the housekeeping genes hypoxanthine phos-
phoribosyltransferase (HPRT) or Villin. Each independent sample was assayed
in duplicate.
Genotyping for Survivin was performed by PCR of tail DNA using the primers
50-TGAGTCGTCTTGGCGGAGGTTGT-30 and 50-GCTCGTTCTCGGTAGGGC
AGTGG-30. For determination of IEC-specific knockout of the Survivin gene,
isolated epithelial cells were used for PCR using the primers 50-GAGTCC
CAGCTTCCAGCGAC-30 and 50-CAGGCAAAACCATGCATGTT-30.
Crypt Isolation, Organoid Culture, and Stainings
For organoid culture, crypts of the small intestine of mice were isolated as
previously described (Sato et al., 2009). Organoids of SurviviniDIEC miceeports 14, 1062–1073, February 9, 2016 ª2016 The Authors 1071
were cultured for at least 5 days and subsequently stimulated with tamoxifen
dissolved in ethanol, further diluted in basal culture medium to a final concen-
tration of 50 ng/ml (Sigma Aldrich). As control, organoids were treated with
ethanol or DMSO, depending on the dissolvent of the stimuli Organoids
derived from Lgr5iDSurvivin mice, and controls were treated with CHIR99021
dissolved in distilled water (3 mM; Selleck Chemicals) and valproic acid dis-
solved in ethanol (1 mM; Biomol) for 3 days before tamoxifen treatment. In
some experiments, organoids were treated with a caspase inhibitor (50 mM;
Santa Cruz Biotechnology) and/or a pharmacological RIPK3-Inhibitor (5 mM;
Calbiochem) or Enbrel (10 mg/ml; Pfizer). Organoid growth was monitored
via light microscopy (Leica, DMI 4000B). In vitro analysis of cell death of orga-
noids was performed using the CaspGlow Red Active Caspase Staining kit
(Biovision) or Cell Viability kit (Roche) according to the manufacturer’s protocol
in combination with Hoechst 33342 (Invitrogen). For confocal images, organo-
ids were washed and embedded in Mowiol (Sigma Aldrich).
Flow Cytometry Analysis
Isolation of crypt cells was described previously (Sato et al., 2009). In short,
crypts were isolated form fresh small intestine using crypt isolation buffer
(PBS + 2 mM EDTA; Roth) and gently rocked for 30 min. at 4C. To get single
cells, isolatedcryptswerepassed througha70-mmcell strainer (BDBiosciences)
and incubated inpre-warmedsingle-cell dissociationmediummadeofbasalcul-
ture medium and Y-27632 (Tocris) for 40–60min. until crypts started to become
loose. Cell suspension was passed through a 40-mm cell strainer (BD Biosci-
ences) followed by a 20-mm cell strainer (Millipore). Single cells were counted
andsurface-stainedusing anti-EpCAMantibody (eBioscience) or isotypecontrol
using anti-rat immunoglobulin G2a, k antibody (BioLegend) as well as Zombie-
Aqua (BioLegend) and washed twice with FACS washing buffer (PBS + 1%
FCS+10mMY-27632). For preservation ofGFPbevor intracellular staining, cells
wereprefixedwith1%PFAfor 15min, andSurvivin stainingwasperformedusing
the FoxP3 Fix/Perm buffer set (BioLegend) after 30-min incubation at 4C pro-
tected from light. Cells were washed twice with permeabilization buffer (eBio-
science) followed by incubation with anti-Survivin antibody (Cell signaling Tech-
nology) or isotype control using anti-rabbit immunoglobulin G XP (Cell Signaling
Technology) for 30 min at 4C protected from light. Cells were resuspended in
200 ml PBS and analyzed on a LSR Fortessa II (BD Biosciences). Data analysis
was performed using FlowJo v7.6.5 (Tree Star). For cell-cycle analysis of intesti-
nal epithelial cells, please see Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed using the Student’s two-tailed t test to
compare two groups. Significance levels are indicated as follows: *p% 0.05,
**p % 0.01, and ***p % 0.001. Data are presented as mean values + or ±
SD. Statistical calculations were performed using standard functions of Micro-
soft Excel and GraphPad PRISM. Image analysis was performed by ImageJ
(NIH), using the integrated density, area of interest, and background readings
as parameters. To eliminate bias, investigators were blinded during data
collection and data analysis. The block randomization method was used to
allocate the animals to experimental group.
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